Published in Breast Cancer Res Treat on June 27, 2007
Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years. Cancer (2014) 2.43
Passive smoking and risk of breast cancer in the California teachers study. Cancer Epidemiol Biomarkers Prev (2009) 1.05
N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women. Toxicol Sci (2009) 0.89
Smoking before the first pregnancy and the risk of breast cancer: a meta-analysis. Am J Epidemiol (2011) 0.88
Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer. Ann Epidemiol (2015) 0.88
Case-control study of tobacco smoke exposure and breast cancer risk in Delaware. BMC Cancer (2008) 0.84
Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One (2013) 0.83
Characterizing the Genetic Basis for Nicotine Induced Cancer Development: A Transcriptome Sequencing Study. PLoS One (2013) 0.83
Cigarette Smoking and Breast Cancer Risk in Hispanic and Non-Hispanic White Women: The Breast Cancer Health Disparities Study. J Womens Health (Larchmt) (2015) 0.80
Passive smoking exposure from partners as a risk factor for ER+/PR+ double positive breast cancer in never-smoking Chinese urban women: a hospital-based matched case control study. PLoS One (2014) 0.79
Environmental tobacco smoke exposure and risk of breast cancer in nonsmoking women. An updated review and meta-analysis. Inhal Toxicol (2016) 0.77
Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women. PLoS One (2017) 0.75
Interleukin-6 (IL-6) rs1800796 and cyclin dependent kinase inhibitor (CDKN2A/CDKN2B) rs2383207 are associated with ischemic stroke in indigenous West African Men. J Neurol Sci (2017) 0.75
Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc (2000) 39.79
Survey research in New Mexico Hispanics: some methodological issues. Am J Epidemiol (1983) 4.59
Moderate physical activity patterns of minority women: the Cross-Cultural Activity Participation Study. J Womens Health Gend Based Med (1999) 3.40
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20
Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat (1982) 2.98
Significance of interleukin-6 (IL-6) in breast cancer (review). Breast Cancer Res Treat (2006) 2.89
Active and passive smoking in breast cancer: prospective results from the Nurses' Health Study. Epidemiology (2002) 2.86
Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet (2002) 2.79
Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst (2004) 2.62
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41
Cigarette smoking and the risk of breast cancer in women: a review of the literature. Cancer Epidemiol Biomarkers Prev (2002) 2.39
Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer (2006) 2.31
AKT activation predicts outcome in breast cancer patients treated with tamoxifen. J Pathol (2005) 2.20
A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer. Carcinogenesis (1997) 1.84
Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol (2002) 1.73
Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet (2003) 1.56
Estrogen receptor genotypes and haplotypes associated with breast cancer risk. Cancer Res (2004) 1.52
Cigarette smoking and breast cancer risk: update of a prospective cohort study. Breast Cancer Res Treat (2006) 1.42
Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab (2003) 1.38
Active and passive smoking and risk of breast cancer by age 50 years among German women. Am J Epidemiol (2002) 1.38
The relationship between various measures of cigarette smoking and risk of breast cancer among older women 65-79 years of age (United States). Cancer Causes Control (2005) 1.20
Smoking associated with hormone receptor negative breast cancer. Int J Cancer (2001) 1.17
IL6, aspirin, nonsteroidal anti-inflammatory drugs, and breast cancer risk in women living in the southwestern United States. Cancer Epidemiol Biomarkers Prev (2007) 1.16
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. Mayo Clin Proc (2005) 1.12
Smoking (active and passive) and breast cancer: epidemiologic evidence up to June 2001. Environ Mol Mutagen (2002) 1.10
Is the association between cigarette smoking and breast cancer modified by genotype? A review of epidemiologic studies and meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.10
Differential effect of NAT2 on the association between active and passive smoke exposure and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2002) 1.09
Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer. Carcinogenesis (2002) 1.07
Mutagenic activity in nipple aspirates of human breast fluid. Cancer Res (1980) 1.07
Manganese superoxide dismutase polymorphism, plasma antioxidants, cigarette smoking, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.06
Cigarette smoking and effects on hormone function in premenopausal women. Environ Health Perspect (2005) 1.05
NAT2 slow acetylation and GSTM1 null genotypes may increase postmenopausal breast cancer risk in long-term smoking women. Pharmacogenetics (2003) 1.04
The estrogen receptor alpha gene and breast cancer risk (The Netherlands). Cancer Causes Control (2005) 1.01
Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival. Clin Cancer Res (2005) 0.99
ESR1, AR, body size, and breast cancer risk in Hispanic and non-Hispanic white women living in the Southwestern United States. Breast Cancer Res Treat (2006) 0.97
Association of estrogen receptor alpha polymorphisms with breast cancer risk in older Caucasian women. Int J Cancer (2005) 0.92
Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res (1996) 0.90
Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival. Breast Cancer Res (2006) 0.87
Molecular and cellular basis of the mammary gland susceptibility to carcinogenesis. Environ Health Perspect (1983) 0.87
Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence. Int J Cancer (1999) 0.86
N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer. Cancer Detect Prev (2004) 0.83
Breast cancer, passive and active cigarette smoking and N-acetyltransferase 2 genotype. Pharmacogenetics (2002) 0.78
Re: Hunter, D.J., Hankinson, S.E., Hough, H. et al. (1997), A prospective study of NAT2 acetylation genotype, cigarette smoking and risk of breast cancer. Carcinogenesis, 18, 2127-2132. Carcinogenesis (1998) 0.77
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol (2005) 9.67
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med (2015) 7.99
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology (2005) 6.34
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res (2005) 5.68
Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin (2012) 4.77
HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med (2011) 4.69
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69
Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis (2006) 4.67
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine (2008) 4.31
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study. Lancet (2013) 3.25
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res (2006) 3.05
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine (2006) 2.78
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2003) 2.77
Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients. Breast Cancer Res Treat (2005) 2.75
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Lifestyle interventions to reduce cancer risk and improve outcomes. Am Fam Physician (2008) 2.54
High- and low-fat dairy intake, recurrence, and mortality after breast cancer diagnosis. J Natl Cancer Inst (2013) 2.46
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine (2011) 2.43
Body size, weight change, fat distribution and breast cancer risk in Hispanic and non-Hispanic white women. Breast Cancer Res Treat (2007) 2.41
Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol (2008) 2.38
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer (2007) 2.36
Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol (2010) 2.31
Anticancer vitamins du Jour--The ABCED's so far. Am J Epidemiol (2010) 2.30
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Using multiple data features improved the validity of osteoporosis case ascertainment from administrative databases. J Clin Epidemiol (2008) 2.19
Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis. BMC Infect Dis (2011) 2.19
Male circumcision and genital human papillomavirus: a systematic review and meta-analysis. Sex Transm Dis (2012) 2.16
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study. Breast Cancer Res (2011) 2.13
Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis (2010) 2.10
Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01
The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst (2011) 2.00
The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev (2010) 1.94
Incidence trends in primary malignant penile cancer. Urol Oncol (2007) 1.90
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
New American Cancer Society process for creating trustworthy cancer screening guidelines. JAMA (2011) 1.88
Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (2008) 1.88
Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis (2004) 1.87
Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev (2007) 1.87
A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum (2009) 1.85
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis (2011) 1.84
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
Prevalence of and risk factors for anal human papillomavirus infection in men who have sex with women: a cross-national study. J Infect Dis (2010) 1.83
Fat, protein, and meat consumption and renal cell cancer risk: a pooled analysis of 13 prospective studies. J Natl Cancer Inst (2008) 1.81
Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res (2012) 1.80
Factors associated with acquisition and clearance of human papillomavirus infection in a cohort of US men: a prospective study. J Infect Dis (2009) 1.80
The impact of a promotora on increasing routine chronic disease prevention among women aged 40 and older at the U.S.-Mexico border. Health Educ Behav (2004) 1.78
Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis (2009) 1.74
Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis (2003) 1.74
The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res (Phila) (2010) 1.73
First-degree relatives of patients with advanced colorectal adenomas have an increased prevalence of colorectal cancer. Clin Gastroenterol Hepatol (2003) 1.73
Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat (2008) 1.69
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66
Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol (2010) 1.66
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis (2011) 1.64
Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat (2008) 1.60
Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study. Cancer Causes Control (2008) 1.60
Dietary supplements and cancer prevention: balancing potential benefits against proven harms. J Natl Cancer Inst (2012) 1.60
Risk factors for anogenital human papillomavirus infection in men. J Infect Dis (2007) 1.59
Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer (2004) 1.59
Association between sulfotransferase 1A1 genotype and survival of breast cancer patients receiving tamoxifen therapy. J Natl Cancer Inst (2002) 1.58
Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2005) 1.56
Prevalence of and risk factors for anal human papillomavirus infection in heterosexual men. J Infect Dis (2008) 1.55
Echinacea and truth in labeling. Arch Intern Med (2003) 1.54
APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res (2007) 1.54
Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine (2007) 1.53
Amplification and overexpression of E2F3 in human bladder cancer. Oncogene (2004) 1.52
Body mass index and colon cancer: an evaluation of the modifying effects of estrogen (United States). Cancer Causes Control (2003) 1.52
Sustaining the Clinical and Translational Research Workforce: Training and Empowering the Next Generation of Investigators. Acad Med (2015) 1.52
MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer (2010) 1.51
Physical activity patterns and obesity in Hispanic and non-Hispanic white women. Med Sci Sports Exerc (2006) 1.51
NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat (2006) 1.50
Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev (2007) 1.49